Immunotherapy at all stages of hepatocellular carcinoma

David J Pinato^{1

2}, Claudia A M Fulgenzi³, Antonio D'Alessio^{3

4}

Affiliations

¹ Department of Surgery and Cancer, Hammersmith Hospital Campus, Imperial College London, London, UK. david.pinato@imperial.ac.uk.
² Department of Translational Medicine, Università Del Piemonte Orientale "A. Avogadro", Novara, Italy. david.pinato@imperial.ac.uk.
³ Department of Surgery and Cancer, Hammersmith Hospital Campus, Imperial College London, London, UK.
⁴ Department of Translational Medicine, Università Del Piemonte Orientale "A. Avogadro", Novara, Italy.

David J Pinato et al. Nat Med. 2024 Mar.

. 2024 Mar;30(3):640-641.

doi: 10.1038/s41591-024-02828-8.

David J Pinato^{1

2}, Claudia A M Fulgenzi³, Antonio D'Alessio^{3

4}

¹ Department of Surgery and Cancer, Hammersmith Hospital Campus, Imperial College London, London, UK. david.pinato@imperial.ac.uk.
² Department of Translational Medicine, Università Del Piemonte Orientale "A. Avogadro", Novara, Italy. david.pinato@imperial.ac.uk.
³ Department of Surgery and Cancer, Hammersmith Hospital Campus, Imperial College London, London, UK.
⁴ Department of Translational Medicine, Università Del Piemonte Orientale "A. Avogadro", Novara, Italy.

No abstract available

References

1. Wang, K. et al. Nat. Med. https://doi.org/10.1038/s41591-023-02786-7 (2024). - DOI - PubMed - PMC
1. Kim, H.-D. et al. Nat. Med. https://doi.org/10.1038/s41591-024-02824-y (2024). - DOI - PubMed - PMC
1. Qin, S. et al. Lancet 402, 1835–1847 (2023). - DOI - PubMed
1. de Gramont, A. et al. Lancet Oncol. 13, 1225–1233 (2012). - DOI - PubMed
1. Wakelee, H. A. et al. Lancet Oncol. 18, 1610–1623 (2017). - DOI - PubMed - PMC